The Analyst™

Comprehensive diagnosis of your symptoms

Healthy

  Test AMAS (AntiMalignin Antibody Screen)  
 
Search treatments and conditions

 

AMAS blood testing can be useful for the early detection of cancer. In breast cancer, the test can detect the presence of cancerous cells up to 18 months before more conventional detection methods. This is an FDA approved test which has proved useful in early detection and monitoring treatment. The test results should return to normal within 3 months after successful treatment for cancer, otherwise cancerous cells remain. The test will not tell you where the cancer is located, just whether it is present or not. Additional information is available from Oncolab, located in Boston, Massachusetts and other Internet sources.
 

 
 

Test AMAS (AntiMalignin Antibody Screen) can help with the following:
 
 
Risks  Cancer / Risk - General Measures
  Increased Risk of Breast Cancer
  Increased Risk of Esophageal Cancer
  Increased Risk of Stomach Cancer
  Increased Risk of Colon Cancer
  Increased Risk of Rectal Cancer
  Increased Risk of Pancreatic Cancer
  Increased Risk of Cancer Of The Larynx
  Increased Risk of Endometrial Cancer
  Increased Risk of Ovarian Cancer
  Increased Risk of Liver Cancer
  Increased Risk of Prostate Cancer
  Increased Risk of Melanoma
  Increased Risk of Basal Cell Skin Cancer
  Increased Risk of Squamous Cell Skin Cancer
  Increased Risk of Cervical Cancer
  Increased Risk of Bladder Cancer
  Increased Risk of Brain Cancer
  Increased Risk of Lymphoma
  Increased Risk of Multiple Myeloma
  Increased Risk of Leukemia
  Increased Risk of Sarcoma
  Increased Risk of Testicular Cancer
  Increased Risk of Kidney Cancer
  Increased Risk of Bile Duct Cancer
  Increased Risk of Thyroid Cancer
  Increased Risk of Lung Cancer

Tumors, Malignant

  Prostate Cancer
 
 


KEY
May do some good
Likely to help